Internet-delivered Cognitive Behavioural Therapy for Persons With Stroke

Sponsor
Lawson Health Research Institute (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05243615
Collaborator
(none)
100
2
12

Study Details

Study Description

Brief Summary

Approximately 30% of people with stroke experience symptoms of depression. Many may benefit from access to mental health services that target unhelpful thoughts, such as cognitive behaviour therapy (CBT), but go untreated due to lack of access to specialized care, costs, remote location, or stigma related to seeking care. Internet Cognitive Behavioural Therapy (ICBT) may overcome these barriers. The stroke ICBT program teaches skills such as challenging unhelpful thoughts, memory and attention, managing related physical symptoms, and pacing through a mix of online learning and weekly contact with a trained Guide. While the program's content was found to be acceptable among individuals after stroke, the program's effectiveness still needs to be evaluated. Thus, the primary purpose of this study is to evaluate if the stroke ICBT program will improve symptoms of depression compared to an attention control group. Individuals in both groups will answer questions about themselves and their injury and describe symptoms of depression, quality of life, and health service use to evaluate its impact on people's wellbeing. The study results will be useful in determining if the ICBT program is effective and whether it should be part of routine clinical practice.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Guided internet delivered cognitive behavioural therapy
  • Behavioral: Stroke rehabilitation mental health education
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Internet-delivered Cognitive Behavioural Therapy for Persons With Stroke: Randomized Controlled Trial
Anticipated Study Start Date :
Sep 1, 2022
Anticipated Primary Completion Date :
Sep 1, 2023
Anticipated Study Completion Date :
Sep 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Stroke internet delivered cognitive behavioural therapy

A 10-week internet-delivered cognitive behavioural therapy (ICBT) will be delivered to participants who have sustained a stroke. In addition to the online program, a Guide with experience delivering ICBT will provide support by email or phone call once a week. The Guide will spend approximately 15 minutes per week/per client.

Behavioral: Guided internet delivered cognitive behavioural therapy
A 10-week internet-delivered cognitive behavioural therapy (ICBT) will be delivered to participants who have sustained a stroke. In addition to the online program, a Guide with experience delivering ICBT will provide support by email or phone call once a week. The Guide will spend approximately 15 minutes per week/per client.

Active Comparator: Stroke Rehabilitation Education

A 10-week stroke-specific rehabilitation education program for stroke patients in usual care at specialized stroke rehabilitation units. The lessons will include information on spinal cord injury rehabilitation: 1)stroke basics, 2)mental health after stroke, 3)pain after stroke, 4)understanding rehabilitation 5)summary of lessons through an online platform. A Guide will check in with participants once a week to answer any content-related questions. The Guide will spend approximately 15 minutes per week/per client.

Behavioral: Stroke rehabilitation mental health education
A 10-week stroke-specific rehabilitation education program for stroke patients in usual care at specialized stroke rehabilitation units. The lessons will include information on spinal cord injury rehabilitation: 1)stroke basics, 2)mental health after stroke, 3)pain after stroke, 4)understanding rehabilitation 5)summary of lessons through an online platform. A Guide will check in with participants once a week to answer any content-related questions. The Guide will spend approximately 15 minutes per week/per client.

Outcome Measures

Primary Outcome Measures

  1. Change in depression [baseline, 10 weeks, 3 months]

    Measured by Patient Health Questionnaire - 9 Item (PHQ-9), higher scores indicate worse outcomes

  2. Change in anxiety [baseline, 10 weeks, 3 months]

    Measured by Generalize Anxiety Disorder - 7 Item (GAD7)higher scores indicate worse outcomes

Secondary Outcome Measures

  1. Change in quality of life symptoms [baseline, 10 weeks, 3 months]

    Measured by VAS on the EuroQol-5D (EQ5D), higher scores indicate better outcomes

  2. Self-efficacy [baseline, 10 weeks, 3 months]

    Measured by Self-Efficacy for managing Chronic Disease-6 (SEMCD), higher scores indicate better outcomes

  3. Change in perceived disability [baseline, 10 weeks, 3 months]

    Measured by The World Health Organization Disability Assessment Schedule ,(WHODAS), higher scores indicate worse outcomes

  4. Treatment credibility [baseline, 10 weeks]

    Measured by Treatment Credibility Questionnaire (TCQ) which contains 4 items. The first three items range from 0-9 with higher scores indicating better outcome, and the fourth item ranges from 0-100%, with higher scores indicating greater improvement in functioning.

  5. Treatment satisfaction [baseline, 10 weeks]

    Measured by Internet-CBT Treatment Satisfaction Measure, higher scores indicate greater satisfaction

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 18 years of age or older;

  • Canadian residents;

  • diagnosed with a stroke at least 6 months ago;

  • endorsing symptoms of depression (PHQ-9≥5); 5) suicide risk score <8 (Suicide Behaviours Questionnaire);

  • speak and read English;

  • able to access and be comfortable using computers and the internet;

  • willing to provide a physician as an emergency contact.

Exclusion Criteria:
  • significant cognitive impairment, a score of <21 on the Telephone Interview for Cognitive Status;

  • aphasia, with significant language impairment;

  • currently involved in another psychotherapeutic intervention;

  • present with a severe mental health disorder requiring in-person therapy (e.g., severe suicidal ideation, severe substance abuse, a recent history of psychosis or mania).

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Lawson Health Research Institute

Investigators

  • Principal Investigator: Robert Teasell, MD, Western University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Swati Mehta, Scientist, Lawson Health Research Institute
ClinicalTrials.gov Identifier:
NCT05243615
Other Study ID Numbers:
  • 12132
First Posted:
Feb 17, 2022
Last Update Posted:
May 18, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Swati Mehta, Scientist, Lawson Health Research Institute
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 18, 2022